# Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism

> **NCT00674440** · PHASE2 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 106 (actual)

## Conditions studied

- Congenital Hyperinsulinism
- Hyperinsulinism
- Persistent Hyperinsulinemic Hypoglycemia of Infancy
- CHI
- PHHI

## Interventions

- **DRUG:** F-DOPA
- **RADIATION:** PET scan

## Key facts

- **NCT ID:** NCT00674440
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2008-12
- **Final completion:** 2009-01
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2022-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00674440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00674440, "Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00674440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*